Employers may also consider setting a higher body mass index (BMI) threshold for coverage eligibility, such as at 35 (class II obesity) or 40 (class III obesity)
Sobo may also discuss nutrition, resistance training, sleep, inflammation, hormones, thyroid function, weight management, and recovery habits that affect whether a treatment plan is likely to help
Ensuring better data collection from these underserved populations is essential to reducing healthcare disparities and should be targeted in future studies
Here are three evidence-based electrolyte protocols designed specifically for people on GLP-1 medications, ranging from minimal intervention to comprehensive coverage
Innovation Rapid innovation in the sector supports the development of novel therapies that could prove even more effective and have fewer side effects
My wife has two patients that have been obtaining compounded Tirzepatide from a weight loss expert on Facebook
